Related Experiment Videos
Expression of beta-amyloid precursor protein in the developing human spinal cord
H Arai1, S Higuchi, S Matsushita
1Department of Neurology, Motojima General Hospital, Gunma, Japan.
Brain Research
|April 11, 1994
Summary
Beta-amyloid precursor proteins (beta-APPs) are expressed in the developing human spinal cord early in gestation. Normal metabolism of beta-APPs does not lead to beta/A4 fragment accumulation in the spinal cord.
Area of Science:
- Neuroscience
- Developmental Biology
- Biochemistry
Background:
- Beta-amyloid precursor proteins (beta-APPs) are implicated in neurological conditions.
- Understanding beta-APP expression during human development is crucial.
Purpose of the Study:
- To investigate the spatiotemporal expression of beta-APPs in the developing human spinal cord.
- To determine if beta/A4 fragments accumulate during human spinal cord development.
Main Methods:
- Immunohistochemical analysis of human fetal spinal cords (6-21 weeks gestation) using beta-APP antibodies.
- Western blot analysis of fetal spinal cord tissue fractions.
Main Results:
- Beta-APP immunoreactivity was observed in distinct layers of the early fetal spinal cord, diminishing with maturation.
- Prominent beta-APP expression was noted in neuroblasts and, outside the spinal cord, in dorsal root ganglia neurons and myotubules.
- No convincing beta/A4 immunostaining was detected in the spinal cord, despite beta-APP presence.
- Western blots confirmed full-length beta-APP isoforms in fetal spinal cord fractions.
Conclusions:
- Full-length beta-APP isoforms are expressed early in human spinal cord development.
- Normal beta-APP metabolism in the developing spinal cord does not produce significant beta/A4 fragment accumulation.